Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Medtronic
Colorcon
Julphar
McKinsey
Cipla
QuintilesIMS
Moodys
Healthtrust

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016891

« Back to Dashboard

NDA 016891 describes TALWIN COMPOUND, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. Additional details are available on the TALWIN COMPOUND profile page.

The generic ingredient in TALWIN COMPOUND is aspirin; pentazocine hydrochloride. There are twenty-one drug master file entries for this compound. Additional details are available on the aspirin; pentazocine hydrochloride profile page.
Summary for 016891
Tradename:TALWIN COMPOUND
Applicant:Sanofi Aventis Us
Ingredient:aspirin; pentazocine hydrochloride
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength325MG;EQ 12.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Fuji
Julphar
Harvard Business School
Mallinckrodt
Baxter
Fish and Richardson
Federal Trade Commission
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.